UA150097U - Апатит – полимерная дренирующая повязка для лечения инфицированных ран и язв - Google Patents
Апатит – полимерная дренирующая повязка для лечения инфицированных ран и язв Download PDFInfo
- Publication number
- UA150097U UA150097U UAU202104803U UAU202104803U UA150097U UA 150097 U UA150097 U UA 150097U UA U202104803 U UAU202104803 U UA U202104803U UA U202104803 U UAU202104803 U UA U202104803U UA 150097 U UA150097 U UA 150097U
- Authority
- UA
- Ukraine
- Prior art keywords
- ulcers
- treatment
- apatite
- sodium alginate
- dressing
- Prior art date
Links
- 206010052428 Wound Diseases 0.000 title claims abstract description 24
- 208000027418 Wounds and injury Diseases 0.000 title claims abstract description 24
- 208000025865 Ulcer Diseases 0.000 title claims abstract description 17
- 231100000397 ulcer Toxicity 0.000 title claims abstract description 17
- 229910052586 apatite Inorganic materials 0.000 title description 3
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 title description 3
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims abstract description 14
- 229910052588 hydroxylapatite Inorganic materials 0.000 claims abstract description 10
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 claims abstract description 10
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 8
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 8
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 8
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 8
- 239000000661 sodium alginate Substances 0.000 claims abstract description 8
- 239000011787 zinc oxide Substances 0.000 claims abstract description 7
- 238000004108 freeze drying Methods 0.000 claims abstract description 5
- 238000000265 homogenisation Methods 0.000 claims abstract description 5
- 238000007710 freezing Methods 0.000 claims abstract description 4
- 230000008014 freezing Effects 0.000 claims abstract description 4
- 239000011159 matrix material Substances 0.000 claims abstract description 4
- 239000011148 porous material Substances 0.000 claims abstract description 4
- 239000000725 suspension Substances 0.000 claims abstract description 4
- 230000001057 ionotropic effect Effects 0.000 claims abstract description 3
- 229920000867 polyelectrolyte Polymers 0.000 claims abstract description 3
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 3
- 229920001661 Chitosan Polymers 0.000 claims description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 6
- 239000011575 calcium Substances 0.000 claims description 6
- 229910052791 calcium Inorganic materials 0.000 claims description 6
- 230000002950 deficient Effects 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 5
- 229920002521 macromolecule Polymers 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 abstract description 7
- 206010006956 Calcium deficiency Diseases 0.000 abstract 1
- 239000003792 electrolyte Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 description 11
- 239000000243 solution Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- 230000001228 trophic effect Effects 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 244000309464 bull Species 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 2
- 201000002282 venous insufficiency Diseases 0.000 description 2
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 241001442052 Symphytum Species 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000002729 catgut Substances 0.000 description 1
- 229960001139 cefazolin Drugs 0.000 description 1
- MLYYVTUWGNIJIB-BXKDBHETSA-N cefazolin Chemical compound S1C(C)=NN=C1SCC1=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 MLYYVTUWGNIJIB-BXKDBHETSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 201000002816 chronic venous insufficiency Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 210000001608 connective tissue cell Anatomy 0.000 description 1
- ZXJXZNDDNMQXFV-UHFFFAOYSA-M crystal violet Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1[C+](C=1C=CC(=CC=1)N(C)C)C1=CC=C(N(C)C)C=C1 ZXJXZNDDNMQXFV-UHFFFAOYSA-M 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000005021 gait Effects 0.000 description 1
- 229960001235 gentian violet Drugs 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 210000001699 lower leg Anatomy 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 230000017066 negative regulation of growth Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- ABBQGOCHXSPKHJ-WUKNDPDISA-N prontosil Chemical compound NC1=CC(N)=CC=C1\N=N\C1=CC=C(S(N)(=O)=O)C=C1 ABBQGOCHXSPKHJ-WUKNDPDISA-N 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000007632 sclerotherapy Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229950008188 sulfamidochrysoidine Drugs 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000003906 tibiofibular joint Anatomy 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU202104803U UA150097U (ru) | 2021-08-25 | 2021-08-25 | Апатит – полимерная дренирующая повязка для лечения инфицированных ран и язв |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU202104803U UA150097U (ru) | 2021-08-25 | 2021-08-25 | Апатит – полимерная дренирующая повязка для лечения инфицированных ран и язв |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA150097U true UA150097U (ru) | 2021-12-29 |
Family
ID=79188945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU202104803U UA150097U (ru) | 2021-08-25 | 2021-08-25 | Апатит – полимерная дренирующая повязка для лечения инфицированных ран и язв |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA150097U (ru) |
-
2021
- 2021-08-25 UA UAU202104803U patent/UA150097U/ru unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Shi et al. | Selection of appropriate wound dressing for various wounds | |
| Skórkowska-Telichowska et al. | The local treatment and available dressings designed for chronic wounds | |
| WO2016192571A1 (zh) | 作为再生性皮肤替代物的多功能皮肤或创面复合敷料 | |
| Belmin et al. | Sequential treatment with calcium alginate dressings and hydrocolloid dressings accelerates pressure ulcer healing in older subjects: a multicenter randomized trial of sequential versus nonsequential treatment with hydrocolloid dressings alone. | |
| US9101586B2 (en) | Topical application and formulation of erythropoietin for skin wound healing | |
| Park et al. | Collagen dressing in the treatment of diabetic foot ulcer: a prospective, randomized, placebo-controlled, single-center study | |
| Bernstein et al. | Combination of subatmospheric pressure dressing and gravity feed antibiotic instillation in the treatment of post-surgical diabetic foot wounds: a case series | |
| IT201900000385A1 (it) | Composizione per il trattamento di lesioni e irritazioni cutanee | |
| RU2512681C2 (ru) | Способ лечения длительно незаживающей раны и/или раневой полости | |
| UA150097U (ru) | Апатит – полимерная дренирующая повязка для лечения инфицированных ран и язв | |
| Mukhopadhyay et al. | Speciality dressings for managing difficult-to-heal wounds | |
| EP2255819A1 (en) | Extract of annelid and use thereof for the regeneration of the skin | |
| Mehta et al. | Hydrogel-based Treatment Strategies to Accelerate Diabetic Foot Ulcer Healing | |
| EP1176991B1 (en) | Ceramic wound treatment device | |
| RU2245723C1 (ru) | Средство и способ лечения гнойно-воспалительных заболеваний мягких тканей | |
| US20140030365A1 (en) | Compositions for the debridement, granulation and reepithelialization of wounds in man | |
| JP2004523521A (ja) | 非代謝性の糖質と高分子吸収剤とを用いた細胞再生及び／又は細胞分化の促進 | |
| RU2339399C2 (ru) | Способ лечения ран мягких тканей | |
| RU2775878C1 (ru) | Способ лечения гнойных ран | |
| Chamgordani et al. | An overview of wound healing: wound types and current therapeutics | |
| RU2254813C2 (ru) | Способ лечения ран при огнестрельных ранениях конечностей | |
| Zhao et al. | Application Experience of Moist Wound Healing Theory Combined with Modern New Dressings in the Treatment of Pressure Ulcers | |
| RU2248803C2 (ru) | Способ лечения гнойных ран | |
| GOLDEXBERG | The biology and pathology of the granulation tissue in reparative surgery | |
| RU2220724C1 (ru) | Антимикробное и ранозаживляющее средство "ультракол" |